Related Experiment Video
Updated: Mar 20, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
Identification of a Peptide Produced by Bifidobacterium longum CECT 7210 with Antirotaviral Activity
Empar Chenoll1, Beatriz Casinos1, Esther Bataller1
1Department of AgroFood Biotechnology, Biópolis S.L. Valencia, Spain.
Insights
A probiotic bacterium, Bifidobacterium longum subsp. infantis CECT 7210, produces an 11-amino acid peptide that inhibits rotavirus replication. This peptide, identified as 11-mer, shows potential for enhancing rotavirus vaccine efficacy.
Area of Science:
- Microbiology
- Virology
- Gastroenterology
Background:
- Rotavirus is a primary cause of infant diarrhea and enteritis.
- Probiotics are being investigated to boost rotavirus vaccine effectiveness.
- Bifidobacterium longum subsp. infantis CECT 7210 previously showed in vitro and in vivo rotavirus inhibition.
Purpose of the Study:
- To systematically identify the molecule from B. longum subsp. infantis CECT 7210 responsible for rotavirus inhibition.
- To characterize the inhibitory molecule and its mechanism of action.
Main Methods:
- Supernatant protease digestion to determine the nature of the active substance.
- Cationic exchange chromatography for purification of the inhibitory compound.
- Synthesis and functional verification of the identified peptide against rotavirus strains in cell lines.
- Detection of protease activity in bacterial supernatant.
Main Results:
- The rotavirus inhibitory substance is proteinaceous and released into the supernatant.
- An 11-amino acid peptide (11-mer peptide, MHQPHQPLPPT) was identified as the active molecule.
- The synthesized 11-mer peptide inhibited replication of Wa, Ito, and VA70 rotavirus strains in HT-29 and MA-104 cells.
- Protease activity was detected in the bacterial supernatant, correlating with 11-mer peptide release.
Conclusions:
- The 11-mer peptide produced by B. longum subsp. infantis CECT 7210 directly inhibits rotavirus replication.
- This peptide represents a potential therapeutic or adjuvant agent for improving rotavirus vaccine outcomes.
- Further research into the specific protease involved is warranted.
Abstract:
Rotavirus is one of the main causes of acute diarrhea and enteritis in infants. Currently, studies are underway to assess the use of probiotics to improve rotavirus vaccine protection. A previous work demonstrated that the probiotic strain Bifidobacterium longum subsp. infantis CECT 7210 is able to hinder rotavirus replication both in vitro and in vivo. The present study takes a systematic approach in order to identify the molecule directly involved in rotavirus inhibition. Supernatant protease digestions revealed both the proteinaceous nature of the active substance and the fact that the molecule responsible for inhibiting rotavirus replication is released to the supernatant. Following purification by cationic exchange chromatography, active fractions were obtained and the functional compound was identified as an 11-amino acid peptide (MHQPHQPLPPT, named 11-mer peptide) with a molecular mass of 1.282 KDa. The functionality of 11-mer was verified using the synthesized peptide in Wa, Ito, and VA70 rotavirus infections of both HT-29 and MA-104 cell lines. Finally, protease activity was detected in B. longum subsp. infantis CECT 7210 supernatant, which releases 11-mer peptide. A preliminary identification of the protease is also included in the study.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors of Bacterial Protein Synthesis
Leaky Scanning